Expression of glucose transporters in peripheral blood cells in patients with type 2 diabetes mellitus depending on the mode of therapy

Diabetologia Doswiadczalna i Kliniczna

Volumn 7, Issue 4, 2007, Pages 204-212

  Szablewski, Leszek ^a   Sobczyk Kopcioł, Agnieszka ^a   Oleszczak, Bozenna ^a   Mrozikiewicz Rakowska, Beata ^b   Karnafel, Waldemar ^b   Grytner Ziȩcina, Barbara ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego   (Poland)

Author keywords

Glucose transporters; Peripheral blood cells; Type 2 diabetes mellitus

Indexed keywords

GLICLAZIDE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; INSULIN;

ADULT; AGED; ARTICLE; BLOOD CELL; CELL ISOLATION; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 36849074131     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J 1993; 295: 329-341.
2. Joost HG, Mueckler M, Bell GI. et al. Nomenclature of GLUT//SLC2A family of sugar/polyol transport facilitators. Am J Physiol 2002; 282: E974-E1076.
3. Joost HG, Thorens B. The extended GLUT-family of sugar//polyol transport facilitators: nomenclature, sequence chara-cteristics, and potential function of its novel members. Mol Membr Biol 2001; 18: 246-256.
4. Longo M, Elsas LJ. Human glucose transporters. Adv Pediatr 1998; 45: 293-313.
5. Mueckler M, Caruso C, Baldwin SA. et al. Sequence and structure of a human glucose transporter. Science 1985; 229: 941-945.
6. Pessin IE, Bell GI. Mammalian facultative glucose transporter family: structure and molecular regulation. Ann Rev Physiol 1992; 54: 922-930.
7. Daneman D, Zinman B, Elliott ME, Bilan PI, Klip A. Insulin-stimulated transport in circulating mononuclear cells from nondiabetic and IDDM subjects. Diabetes 1992; 41: 227-234.
8. Doege H, Bocianski A, Joost HG, Schürmann A. Activity and genomic organization of human glucose transporter 9 (GLUT 9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 2000; 350: 771-776.
9. Estrada DE, Elliott E, Zinman B. et al. Regulation of glucose transport and expression of GLUT 3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals. Metab Clin Exp 1994; 43: 591-598.
10. Fu Y, Maianu L, Melbert BR, Garvey WT. Facultative glucose transporter gene expression in human lymphocytes, monocytes and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004; 32: 182-190.
11. Korgun ET, Demir R, Sedlmayr P. et al. Physiological leukocytosis during pregnancy is associated with changes in glucose transporter expression of maternal peripheral blood granulocytes and monocytes. Am J Reprod Immunol 2002; 48: 110-116.
12. Korgun ET, Demir R, Sedlmayr P. et al. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 2002; 28: 152-159.
13. Badr GA, Tang J, Ismail-Beigi F, Kern TS. Diabetes downregulates GLUT 1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes 2000; 49: 1016-1021.
14. Kumagai AK. Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab Res Rev 1999; 15: 261-273.
15. Hahn T, Barth S, Weiss U, Mosgoeller W, Desoye G. Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transporter system of cultured human term placental trophoblast: a mechanism to protect fetal development. FASEB J 1998; 12: 1221-1231.
16. Li H, Gu Y, Zhang Y, Lucas MJ, Wang Y. High glucose levels down-regulate glucose transporter expression that correlates with increased oxidative stress in placental trophoblast cells in vitro. J Soc Gynecol Invest 2004; 11: 75-81.
17. Jansson T, Wennergeren M, Powell TL. Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. Am J Obstet Gynecol 1999; 180: 163-168.
18. Kainulainen H, Järvinen T, Heinonen PK. Placental glucose transporters in fetal intrauterine growth retardation and macrosomia. Gynecol Obstet Invest 1997; 44: 89-92.
19. Heilig CW, Liu Y, Eugland RL. et al. D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-1 sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy. Diabetes 1997; 46: 1030-1039.
20. McCall AL, Van Bueren AM, Nipper V, Moholt-Siebert M, Downes H, Lessov N. Forebrain ischemia increases Glut1 protein in brain microvessels and parenchyma. J Cereb Blood Flow Metab 1996; 16: 69-76.
21. Duelli R, Staudt R, Duembgen L, Kuschinsky W. Increase in glucose transporter densities of Glut 3 and decrease of glucose utilization in rat brain after one week of hypoglycemia. Brain Res 1999; 831: 254-262.
22. Moriguchi S, Kato M, Sakai K, Yamamoto S, Shimizu E. Decreased mitogen response of splenic lymphocytes in obese Zucker rats is associated with the decreased expression of glucose transporter 1 (GLUT-1). Am J Clin Nutr 1998; 67: 1124-1129.
23. Harik SI, Behmand RA, Arafah BM. Chronic hyperglycemia increases the density of glucose transporters in human erythrocyte membranes. J Clin Endocrinol Metab 1991; 72: 814-818.
24. Xie WS, Yuc JC, Tu YP. Fluorescence study on ligand induced conformational changes of human erythrocyte glucose transporter. Biochem Mol Biol lnt 1996; 39: 279-284.
25. Hu XJ, Peng F, Zhou HQ, Zhang ZH, Cheng WY, Feng HF. The abnormality of glucose transporter in the erythrocyte membrane of Chinese type 2 diabetic patients. Biochim Biophys Acta 2000; 1466: 306-314.
26. Piatkiewicz P, Szablewski L, Czech A, Tatoń J, Oleszczak B, Sobczyk A. Badanie ekspresji genów GLUT w limfocytach osób zdrowych i chorych na cukrzycȩ typu 2. Diabetologia Polska 2003; 10: 41.
27. Chiang S-H, Baumann C, Kanzaki M. et al. Insulin-stimulated GLUT 4 translocation requires the CAP-dependent activation of TC10. Nature 2001; 6831: 944-948.
28. Jung CY, Lee W. Glucose transporters and insulin action: some insights into diabetes management. Arch Pharm Res 1999; 22: 329-334.
29. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000; 106: 165-169.
30. Shepherd PR, Kahn BB. Mechanism of disease: glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-257.
31. Calderhead DM, Kitagawa K, Tanner L, Holman GD, Lienhard GE. Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes. J Biol Chem 1990; 265: 13800-13808.
32. Imamura H, Morimoto I, Tanaka T. et al. Regulation of glucose transporter 1 expression by gliclazide in rat L6 myoblasts. Diab Nutr Metab 2001; 14: 308-314.
33. Tsiani E, Ramlal T, Leiter LA, Klip A, Fantus IG. Stimulation of glucose uptake and increase plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide. Endocrinol 1995; 136: 2505-2512.
34. Müller G. The molecular mechanism of the insulin-mimetic// sensitizing activity of the antidiabetic sulfonylurea drug amaryl. Mol Med 2000; 6: 907-933.
35. Goodyear LJ, Hirshman MF, Napoli R. et al. Glucose ingestion causes GLUT4 translocation in human skeletal muscle. Diabetes 1996; 45: 1051-1056.
36. Pliszka M, Szablewski L, Oleszczak B. Effects of IGF-1 on deoksy-D-glucose uptake by human peripheral blond lymphocytes. Exptl Clin Diabetol 2006; 6: 314-319.
37. Calderhead DM, Kitagawa K, Tanner L, Holman GD, Lienhard GE. Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes. J Biol Chem 1990; 265: 13800-13808.
38. Cloherty E-K, Heard K-S, Carruthers A. Human erythrocyte sugar transport is incompatible with available carrier models. Biochem 1996; 35: 10411-10421.
39. Kaliman P, Vińals F, Testar X, Palacin M, Zorzano A. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem J 1995; 312: 471-477.
40. Cabeza N, Li Z, Schulz C. et al. Surface expression of collage receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cell. Diabetes 2004; 52: 2117-2121.
41. Szablewski L, Raszka K, Oleszczak B. The influence of hyper-and hypoglycemia on glucose uptake into human circulating lymphocytes. An in vitro study. Diab. Dośw. i Klin. 2007; 3: 131-138.
42. Vestergaard H, Weinreb JE, Rosen AS. et al. Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in non-insulin-dependent diabetes mellitus subjects: a longitudinal study. J Clin Endocrinol Metab 1995; 80: 270-275.